Ticker Details
Qiagen NV Qiagen NV provides sample and assay technologies to extract, purify, amplify, and interpret DNA (Deoxyribonucleic acid), RNA (Ribonucleic acid), and proteins. It also offers kits, assays, related automated systems and bioinformatics solutions.
IPO Date:	July 1, 1996
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$7.25B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 0.94%
Avg Daily Range (30 D):	$0.45 | 1.23%
Avg Daily Range (90 D):	$0.58 | 1.34%

Institutional Daily Volume
Avg Daily Volume:	.94M
Avg Daily Volume (30 D):	1.94M
Avg Daily Volume (90 D):	2.07M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	10,782
Avg Institutional Trade:	$2.57M
Avg Institutional Trade (30 D):	$3.4M
Avg Institutional Trade (90 D):	$3.76M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.89M
Avg Closing Trade (30 D):	$7.8M
Avg Closing Trade (90 D):	$10.6M
Avg Closing Volume:	91.46K

News

May 15, 2026 @ 2:47 PM QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire,... Source: Bragar Eagel & Squire, P.C.

May 14, 2026 @ 5:00 PM Global Cervical Cancer Diagnostics Market to Exhib... Source: Delveinsight

May 14, 2026 @ 7:37 AM Cancer Biomarkers Market Outlook 2026–2031:... Source: Mordor Intelligence

May 13, 2026 @ 5:00 PM Global Colorectal Cancer Diagnostics and Therapeut... Source: Delveinsight

May 12, 2026 @ 5:00 PM Global HPV Testing and Pap Test Market is Expected... Source: Delveinsight

Splits
Jan 08, 2026	19:20
Jan 29, 2025	35:36
Jan 30, 2024	24.25:25
Jan 25, 2017	26:27
Jul 14, 2000	4:1